RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 55.55
-3.65 (-6.17%)
Jun 27, 2025, 4:08 PM HKT
RemeGen Market Cap
RemeGen has a market cap or net worth of 34.83 billion as of June 27, 2025. Its market cap has increased by 54.84% in one year.
Market Cap
34.83B
Enterprise Value
36.98B
Revenue
2.05B
Ranking
n/a
PE Ratio
n/a
Stock Price
55.55
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 34.83B, an increase of 4.30%. That is a compound annual growth rate of 0.91%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 27, 2025 | 35.11B | 150.70% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines | 248.80B |
| Hansoh Pharmaceutical Group Company | 174.21B |
| Innovent Biologics | 136.09B |
| JD Health International | 134.40B |
| WuXi Biologics | 104.57B |
| Sino Biopharmaceutical | 93.72B |
| CSPC Pharmaceutical Group | 91.10B |
| Akeso | 88.01B |